Pricing Log in Create free account

Ascentage Pharma Group International - Unsponsored ADR (AAPG) vs Korsana Biosciences, Inc. (KRSA)

Ascentage Pharma Group International - Unsponsored ADR and Korsana Biosciences, Inc. are both Biotechnology companies. Ascentage Pharma Group International - Unsponsored ADR and Korsana Biosciences, Inc. are of similar size ($1.4B and $1.4B). Across the 8 metrics below, Ascentage Pharma Group International - Unsponsored ADR leads on 6 and Korsana Biosciences, Inc. on 2.

Valuation

Metric AAPG KRSA Biotechnology median
P/E — n/m 10.60
P/S — 9.01 9.40
P/B n/m 3.67 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 8.34 9.02
Earnings yield — (38.12%) (32.88%)
Free cash flow yield 0.00% (24.20%) (23.13%)

Profitability

Metric AAPG KRSA Biotechnology median
Gross margin — 100.00% 68.51%
Operating margin — 0.00% 0.00%
Net margin — 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (98.22%) (51.96%)
Return on assets 0.00% (82.29%) (46.06%)
Return on invested capital 0.00% (115.40%) 0.00%

Growth

Metric AAPG KRSA Biotechnology median
Revenue growth (TTM) — (28.83%) 6.76%
EPS growth (last fiscal year) (177.78%) 8.26% 29.88%
Revenue growth, 5-year CAGR — (14.38%) 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric AAPG KRSA Biotechnology median
Debt to equity 3.70 0.00 0.00
Current ratio 1.22 0.82 4.97
Net debt to EBITDA 0.44 0.65 1.01

Dividend

Metric AAPG KRSA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AAPG KRSA Biotechnology median
Market cap 1.41b 1.39b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack